Talaris Therapeutics, Inc. has been dropped from NASDAQ Biotechnology Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.53 USD | -1.96% | +0.19% | -40.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.68% | 398M | |
+9.15% | 106B | |
-1.08% | 104B | |
+6.96% | 23.25B | |
-11.55% | 22.5B | |
-7.15% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Talaris Therapeutics, Inc.(NasdaqGM: TALS) dropped from NASDAQ Biotechnology Index